Literature DB >> 8695764

Gene fusions encoding chimaeric transcription factors in solid tumours.

P H Sorensen1, T J Triche.   

Abstract

Analysis of chromosomal alterations in human malignancies has revealed recurring genetic changes that are often closely associated with specific subtypes of tumours. Among solid tumours, cytogenetic analysis of a group of primitive sarcomas occurring principally in children and young adults has identified specific non-random chromosomal translocations associated with these malignancies. A number of the translocation breakpoints have now been cloned, revealing the in frame fusion of genes located at each partner breakpoint. The common theme is the expression by these hybrid genes of chimaeric proteins containing functional domains from each fusion partner. These domains confer transcriptional activation or repression, DNA binding specificity, or other novel protein-protein interactions. The net result appears to be the expression of chimaeric oncoproteins that function in transformation by dysregulating gene transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695764     DOI: 10.1006/scbi.1996.0002

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  15 in total

1.  Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.

Authors:  R J Davis; F G Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Primary pulmonary rhabdomyosarcoma in an adult: a case report and review of the literature.

Authors:  Gui-yi Ji; Hui Mao
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

Review 3.  The emerging complexity of gene fusions in cancer.

Authors:  Fredrik Mertens; Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

4.  Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers.

Authors:  Babak Alaei-Mahabadi; Joydeep Bhadury; Joakim W Karlsson; Jonas A Nilsson; Erik Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

5.  Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.

Authors:  Gabriella Gamberi; Stefania Cocchi; Stefania Benini; Giovanna Magagnoli; Luca Morandi; Jennifer Kreshak; Marco Gambarotti; Piero Picci; Licciana Zanella; Marco Alberghini
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

6.  Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors.

Authors:  David Stahl; Andrew J Gentles; Ralf Thiele; Ines Gütgemann
Journal:  Oncoimmunology       Date:  2019-10-13       Impact factor: 8.110

Review 7.  Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 8.  Directly targeting transcriptional dysregulation in cancer.

Authors:  Thomas J Gonda; Robert G Ramsay
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

9.  Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers.

Authors:  Y Sui; Z Yang; S Xiong; L Zhang; K L Blanchard; S C Peiper; W S Dynan; D Tuan; L Ko
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 8.756

10.  Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts.

Authors:  Saral S Desai; Nirmala A Jambhekar
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.